Elite Pharmaceuticals Inc (ELTP)

[WeeZuhl]

5% is totally possible if these drugs are in the shortage list and Elite can deliver....

Even 10%... this is a more aggressive market than Adderal...

This might be the right way of thinking about a generic OxyContin, which is a low-volume high-margin drug, but I'm not sure it is the correct strategy for Norco and Percocet, which are the opposite: high-volume, low-margin drugs. With these drugs, the key to success is finding the sweet spot between price, quality, and AVAILABILITY, and the current team at Elite seems to be very good at this. They are building the Elite label into something that pharmacy buyers will know is a reliable source of quality products, especially Schedule II drugs and drugs in shortage. They seem to be doing an excellent job of getting Elite's drugs listed with distributors and available for the pharmacy buyers to select. You don't have to be the lowest price on the list, as long as you're on the list and you have a well-regarded reputation with product ready to ship. Elite management is doing a good job of finding higher margin opportunities, like the Prasco partnership for Adderall, and I hope to see similar agreements in the future for more of our drugs. In summary, I believe the success of Norco and Percocet should not be judged by the market share obtained but rather by the profitability achieved by most efficiently using their allocated DEA quota. The products on the Elite label should not be the lowest price or highest volume. Elite products are highest quality and reliably available, and it will be important to maintain that reputation across the entire product line.

.